Study to Investigate the Pharmacokinetics & Safety Following One Application of 3 Different Doses 0.5,0.75,& 1.25 gm,a Transdermal Estradiol Cream (VML-0203), in Comparison to a Single Dose of EstroGel 1.25 gm to Healthy Post-menopausal Women.

NCT03556800 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Viramal Limited

Collaborators